Marshall Wace North America’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$6.55M Buy
60,708
+46,459
+326% +$5.31M 0.03% 441
2021
Q2
$1.6M Sell
14,249
-149,318
-91% -$16.8M 0.01% 869
2021
Q1
$17.7M Sell
163,567
-288,542
-64% -$30.9M 0.07% 272
2020
Q4
$48.4M Sell
452,109
-1,547,969
-77% -$149M 0.22% 122
2020
Q3
$175M Sell
2,000,078
-1,298,961
-39% -$122M 1.12% 11
2020
Q2
$324M Buy
3,299,039
+495,184
+18% +$43.6M 2.14% 4
2020
Q1
$214M Buy
2,803,855
+764,094
+37% +$65.1M 1.62% 6
2019
Q4
$181M Buy
2,039,761
+784,623
+63% +$65.1M 0.87% 28
2019
Q3
$95M Buy
1,255,138
+523,132
+71% +$35.9M 0.54% 50
2019
Q2
$53.2M Buy
732,006
+473,892
+184% +$37.2M 0.33% 82
2019
Q1
$20.8M Buy
258,114
+26,928
+12% +$2.2M 0.15% 142
2018
Q4
$21.3M Buy
231,186
+215,253
+1,351% +$18.9M 0.21% 101
2018
Q3
$1.51M Buy
15,933
+3,533
+28% +$335K 0.01% 542
2018
Q2
$1.15M Buy
12,400
+1,494
+14% +$146K 0.01% 899
2018
Q1
$1.03M Buy
+10,906
New +$1.2M 0.01% 992
2017
Q3
Sell
-111,274
Closed -$8.12M 1209
2017
Q2
$8.12M Buy
111,274
+93,060
+511% +$6.26M 0.06% 372
2017
Q1
$1.18M Buy
+18,214
New +$1.15M 0.01% 665
2013
Q4
$1.37M Buy
+25,960
New +$1.28M 0.03% 345

Other funds holding ABBV